From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day
This study provides an inventory of the SCs detected in the EU from 2008-2022, describing their structural evolution by analysing separately four structural features: their core, tail, linker, and linked groups. The range of structural changes is analysed considering key mile-stones, including the...
EMCDDA framework and practical guidance for naming synthetic cannabinoids
This work provides a theoretical framework and a practical hands-on guideline for consistent naming of synthetic cannabinoids, which is easy to understand and can be applied by the forensic community, researchers, clinical practitioners, and policy-makers. The proposed framework builds on the...
Environmental prevention: why do we need it now and how to advance it?
Environmental substance use prevention is an emerging approach that could overcome the limitations of traditional prevention as well as health promotion. Yet, questions of theory, practice and evaluation are to be addressed, as outlined here.
Standard units for cannabis dose
Changes in cannabis policy will align cannabis use more closely with alcohol, benzodiazepines, prescribed opioids and tobacco rather than with currently illegal drugs. We propose the establishment of a Standard Cannabis Unit (SCU) based on quantity of 9-Tetrahydrocannabinol (9-THC), the primary...
The impact of the COVID-19 lockdown on drug service provision in European prisons
This paper aims to describe the impact of the COVID-19 containment measures on the provision of drug treatment and harm reduction services in European prisons in15 countries during the early phase of the pandemic (March –June 2020).